Immunology

FOCIS 2020 Virtual Annual Meeting

FOCIS 2020 Virtual Annual Meeting

"The FOCIS 2020 Virtual Annual Meeting on October 28-31, 2020, brings together an interdisciplinary group of world-renowned physicians and researchers to share the latest findings on diseases impacting the immune system."

FOCIS 2020 will feature:

  • More than 20 scientific sessions, presented by more than 50 top clinicians and researchers from around the globe speaking on cutting-edge topics across immunology and its related fields.
  • Opening Session with Dr. Anthony Fauci, and Keynote Addresses from Nobel Laureate Dr. Tasuku Honjo, Dr. Federica Sallusto and Dr. Irv Weissman.
  • 20th Anniversary presentations from FOCIS founders Dr. David Hafler and Dr. Garry Fathman, Dr. Maria-Grazia Roncarolo, Dr. Carl June, Dr. Marc Feldman and Dr. Gerald Nepom, as well as a prospective look into the next 20 years.
  • Other world-class speakers in the field, including: Dr. Bana Jabri, Dr. Vishva Dixit, Dr. Ira Mellman, Dr. Jane Grogan, Dr. Jason Cyster, Dr. Jenny Ting, Dr. Lydia Lynch, Dr. Shimon Sakaguchi, Dr. Max Krummel, Dr. Megan Levings, Dr. Michael Fishbach, and many more!
  • A special COVID-19 "Immune Response to Vaccines and Infections" plenary session, featuring: Dr. Alessandro Sette, Dr. Barney Graham, Dr. George Yancopoulis, and Dr. Stanley Perlman.

AST members receive a reduced rate on FOCIS membership. New this year, group registration is offered to groups of 3+ with a commonality of organization or working group. For more information visit the FOCIS website or to request the group registration form, please email info@focisnet.org.

 

"Signaling Through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity"

"Signaling Through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity"

Recorded live on Tuesday, May 19th, 2020, from 2:00 PM ET to 3:00 PM ET • Hosted by the Community of Transplant Scientists (COTS)

"Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity"
(Immunity. 2020 Jan 14;52(1):136-150.e6. doi: 10.1016/j.immuni.2019.12.006.)

Watch Video

Joint Meeting 50th Annual Meeting of the German Society for Immunology (DGfI) and 48th Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI)

Joint Meeting 50th Annual Meeting of the German Society for Immunology (DGfI) and 48th Annual Meeting of the Austrian Society for Allergology and Immunology (ÖGAI)

Plenary Sessions

  • Autoimmunity
  • Immune Tolerance
  • Microbiome & Metabolism

Main Symposia

  • Adaptive Immunity
  • Cells in-between Innate and Adaptive Immunity
  • Imaging & Priming of Immune Responses
  • Immunodeficiencies
  • Innate Immunity
  • Neuroimmune Disorders
  • Novel Approaches for Vaccination
  • Transplantation
  • Tumor Immunology

T3 Webinar: "Non-invasive Biomarkers for Allograft Rejection"

T3 Webinar: "Non-invasive Biomarkers for Allograft Rejection"

Speakers:
Barbara Murphy, MD • Icahn School of Medicine at Mount Sinai, New York, NY
Peter Nickerson, MD, FRCPC • University of Manitoba Max Rady College of Medicine, Winnipeg, MB

Moderator:
Peter Heeger, MD • Icahn School of Medicine at Mount Sinai, New York, NY

AST would like to thank the Community of Transplant Scientists (COTS) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending biomarkers for allograft rejection as a topic for the 2019-2020 T3 series.

Transplant Immunosuppression 2019

Transplant Immunosuppression 2019

"Transplant Immunosuppression 2019: Hot Topics" will focus on current options for immunosuppression (and what’s in the pipeline), with particular attention to individualization of immunosuppression based on clinical and/or laboratory parameters; prevention, diagnosis and treatment of antibody-mediated rejection; improving long-term transplant outcomes; and major issues in transplant-related infectious disease, living donation, and patient-centered care.

There will be “how I do it” sessions where experts discuss how they care for patients with specific transplant issues. A major component of the course will be the opportunity to interact with faculty who use different approaches, and to understand their rationale. "Transplant Immunosuppression" will also offer a precourse for Transplant Coordinators.

Up to 24.0 AMA PRA Category 1 Credits™ and up to 24.0 ANCC contact hours are available. This activity is also eligible for ACPE credit.

This course is endorsed by the American Society of Transplantation.

 

More Information

 

CRISPR Genetics and transplantation (Tx10 Series)

"CRISPR Genetics and transplantation" was recorded at ATC 2018 as part of our Transplant in 10 (Tx10) educational series. Visit our Tx10 page to view the corresponding video for this session.

Speaker: A. Joseph Tector, MD, PhD, University of Alabama

Date: 
Monday, August 6, 2018
Presenter: 
A. Joseph Tector, MD, PhD, University of Alabama
Education Category: 

Drug-Drug interactions and immunosuppression (Tx10 Series)

"Drug-Drug interactions and immunosuppression" was recorded at ATC 2018 as part of our Transplant in 10 (Tx10) educational series. Visit our Tx10 page to view the corresponding video for this session.

Speaker: Steve Gabardi, PharmD, BCPS, FAST, FCCP

Date: 
Monday, August 6, 2018
Presenter: 
Steve Gabardi, PharmD, BCPS, FAST, FCCP

Complications of Immunosuppression (Tx10 Series)

"Complications of Immunosuppression" was recorded at ATC 2016 as part of our Transplant in 10 (Tx10) educational series. Visit our Tx10 page to view the corresponding video for this session.

Date: 
Monday, June 13, 2016
Presenter: 
Alexander C. Wiseman, MD, University of Colorado at Denver and Health Sciences Center
Education Category: 

Fundamentals of Basic Transplant Immunology (Tx10 Series)

"Fundamentals of Basic Transplant Immunology" was recorded at ATC 2016 as part of our Transplant in 10 (Tx10) educational series. Visit our Tx10 page to view the corresponding video for this session.

After listening, the learner will be able to: 1. Identify the targets of the immune system upon transplantation; 2. Describe the key immune cells and pathways involved in rejection; 3. Explain the different patterns of immunological injury to the allograft.

Date: 
Monday, June 13, 2016
Presenter: 
Allan D. Kirk, MD, PhD, FACS, Duke University School of Medicine
Education Category: 

Pages

Subscribe to RSS - Immunology